Dan Lemaitre - Nov 21, 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Nov 21, 2024
Transactions value $
-$286,799
Form type
4
Date filed
11/25/2024, 04:31 PM
Previous filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $864K +13.3K $65.05 13.3K Nov 21, 2024 Direct
transaction GMED Class A Common Stock Sale -$1.13M -13.3K -100% $85.00 0 Nov 21, 2024 Direct
transaction GMED Class A Common Stock Options Exercise $71.4K +1.1K $65.05 1.1K Nov 22, 2024 Direct
transaction GMED Class A Common Stock Sale -$93.3K -1.1K -100% $85.02 0 Nov 22, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -13.3K -88.52% $0.00 1.72K Nov 21, 2024 Class A Common Stock 13.3K $65.05 Direct F1
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -1.1K -63.7% $0.00 625 Nov 22, 2024 Class A Common Stock 1.1K $65.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on January 14, 2021 and are fully vested.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.